Upload File

v-atpase inhibitors in cancer treatment

prev
next
out of 21
Download V-ATPase Inhibitors in Cancer Treatment

Upload: chio-a-gonzalez

Post on 06-Jul-2018

222 views

Category:

Documents


0 download

Report

TRANSCRIPT

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    1/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    2/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    3/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    4/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    5/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    6/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    7/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    8/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    9/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    10/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    11/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    12/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    13/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    14/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    15/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    16/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    17/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    18/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    19/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    20/21

  • 8/17/2019 V-ATPase Inhibitors in Cancer Treatment

    21/21


PI3K𝛅 Inhibitors in Cancer: Rationale and Serendipity …...Review PI3K𝛅 Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic David A. Fruman1 and Christian Rommel2

Tyrosine Kinase Inhibitors in Cancer: Breakthrough and

PARP Inhibitors: Usurping DNA repair to target cancer

Targeting cancer with small molecule kinase inhibitors - SDJ webpage

Use of 5 -Reductase Inhibitors for Prostate Cancer

Recent progress of targeted kinase inhibitors in thyroid cancer

Article SGLT2 inhibitors and risk of cancer in type 2

PARP Inhibitors for the Management of Ovarian Cancer

Cancer Chemotherapy - Doctor 2017 - JU Medicine€¦ · Cancer Chemotherapy ⚫Classes of Anticancer Drugs: ⚫Signal Transduction Inhibitors. ⚫Microtubule Inhibitors. ⚫Differentiation

Protease Inhibitors as Cancer Chemopreventive Agents978-1-4615-2882-1/1.pdf · Protease Inhibitors as Cancer Chemopreventive Agents Edited by Walter Troll New York University Medical

AXL inhibitors as cornerstone of combination cancer therapy1 AXL inhibitors as cornerstone of combination cancer therapy First-in-class medicines to treat aggressive cancers Third

Stage IIIB Epithelial Ovarian Cancer: Recurrent 13 Months … · 2018-05-23 · sensitive ovarian cancer released this year are related to PARP inhibitors. PARP inhibitors are key

MCL-1 INHIBITORS FOR THE TREATMENT OF CANCER Fesik.pdf · MCL-1 INHIBITORS FOR THE TREATMENT OF CANCER. Steve Fesik, Ph.D. Professor of Biochemistry, Pharmacology, and Chemistry

Role of protein tyrosine kinase inhibitors in cancer ...nopr.niscair.res.in/bitstream/123456789/33808/1/IJBB 41(6) 273-280.pdf · Role of protein tyrosine kinase inhibitors in cancer

Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer

Kinase Inhibitors and Ovarian Cancer - MDPI

DNA Repair Inhibitors in Ovarian Cancer: Current Status ... · DNA Repair Inhibitors in Ovarian Cancer: Current Status and Future Strategies Stanley B. Kaye, MD Royal Marsden Hospital

National Prostate Cancer GP Referral Guideline · National Prostate Cancer GP Referral Guideline: Specific information on 5α-reductase inhibitors: • 5α-reductase inhibitors reduce

Targeting DNA Repair in Cancer : Beyond PARP Inhibitors · 20 | CANCER DISCOVERYJANUARY 2017 REVIEW Targeting DNA Repair in Cancer : Beyond PARP Inhibitors Jessica S. Brown 1, Brent

Phyto-polyphenols as potential inhibitors of breast cancer … · 2018. 6. 5. · REVIEW Open Access Phyto-polyphenols as potential inhibitors of breast cancer metastasis Dimiter

HDAC inhibitors in prostate cancer cells

Histone deacetylase inhibitors induce thyroid cancer-specific

Small Molecule Inhibitors of Stat3 Protein as Cancer ...€¦ · Small Molecule Inhibitors of Stat3 Protein as Cancer Therapeutic Agents Brent D. G. Page Doctorate of Philosophy Department

AXL inhibitors as a cornerstone of combination cancer therapy€¦ · AXL inhibitors as a cornerstone of combination cancer therapy Corporate Update April 2018 Richard Godfrey, CEO

V-ATPase Inhibition Regulates Anoikis Resistance and Metastasis … · Cancer Biology and Signal Transduction V-ATPase Inhibition Regulates Anoikis Resistance and Metastasis of Cancer

AKT inhibitors promote cell death in cervical cancer ... · AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake Ramachandran

Immune checkpoint inhibitors, lymphocytes, and … checkpoint inhibitors, lymphocytes, and breast cancer ... tutorial for stromal TILs ... Immune checkpoint inhibitors, lymphocytes,

CANCER Copyright © 2020 Irreversible TrxR1 inhibitors ...CANCER Irreversible TrxR1 inhibitors block STAT3 activity ... and STAT3 oxidation, which subsequently blocked STAT3-dependent

SEDA-19€¦ · Web viewFor example, cardiac glycosides can be considered as ligands that act by binding to their receptor (the Na/K-ATPase), as inhibitors of an enzyme (the Na/K-ATPase),

EGFR Inhibitors in Colorectal Cancer John L. Marshall, MD Lombardi Comprehensive Cancer Center

ROLE OF SODIUM/POTASSIUM ATPase INHIBITORS IN … · ROLE OF SODIUM/POTASSIUM ATPase INHIBITORS IN HYPERTENSIVE AND CARDIOVASCULAR DISORDERS AND IN KIDNEY DISEASE PROGRESSION Jules

Making WavesAGAINST LUNG CANCER · inhibitors to treat patients with advanced lung cancer, his colleagues were skeptical. Simply put, checkpoint inhibitors relieve brakes put on the

Combining Intralesional Therapies & Checkpoint Inhibitors€¦ · Combining Intralesional Therapies & Checkpoint Inhibitors Sanjiv Agarwala, MD Temple University . St Luke’s Cancer

Na,K-ATPase isoform-selective cardiac glycosides - a potential anti-cancer drug ?

Immune checkpoint inhibitors of PD-L1 as cancer therapeuticsImmune checkpoint inhibitors of PD-L1 as cancer therapeutics Akintunde Akinleye* and Zoaib Rasool Abstract Since the discovery